The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Emoxypine Succinate
CAS registry number (Chemical Abstracts Service)
0127464-43-1
Chemical Formula
C8-H11-N-O·(C4H6O4)
Molecular Weight
255
Therapeutic Categories
Anxiolytic agent
Antiplatelet agent
Pharmaceutic aid: Antioxidant
Chemical Names
2-Ethyl-6-methyl-3-hydroxypyridine succinate
Butanedioic acid; 2-ethyl-6-methylpyridin-3-ol (IUPAC)
Foreign Name
- Emoxypin succinat (German)
Generic Names
- Ethylmethylhydroxydepyridine Succinate (IS)
- Hydroxymethylethylpyridine succinate (IS)
- LS-45744 (IS)
- Mexidol (IS)
Brand Names
- Antitromb
Lubnypharm, Georgia - Cogniver
GMP, Georgia; Mefar Ilaç Sanayii, Georgia - Dilox
Aversi, Georgia - Elfunat
Mefar Ilaç Sanayii, Georgia; Rompharm, Georgia - Emoprox
Rompharm, Georgia; World Medicine, Georgia - Emoqsi-Optik
Sintez, Georgia - Mexaron
EuroMedical, Georgia - Mexib 6 Geo [+ Pyridoxine]
Canonpharma, Georgia - Mexibat
Ynnovas, Georgia - Mexibel
Rue Belmedpreparaty, Georgia - Mexicor
EkoPharmInvest, Russian Federation - Mexidol
Ellara, Georgia; Pharmasoft, Russian Federation; Zdorovie, Georgia - Mexilek
Lekfarm, Georgia - Mexiprim
Nizhpharm, Russian Federation; Polysan, Georgia - Neiroks
Sotex, Georgia - Ynnomex
Ynnovas, Georgia
Glossary
| Term | Definition |
|---|---|
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
